المؤلفون: Chen LY; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Shah R; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Cwynarski K; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Lambert J; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., McNamara C; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Mohamedbhai SG; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Virchis A; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Townsend W; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., D'Sa S; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Ardeshna KM; Lymphoma service, Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.

المصدر: British journal of haematology [Br J Haematol] 2019 Feb; Vol. 184 (3), pp. 462-465. Date of Electronic Publication: 2018 Jan 24.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Hematologic Neoplasms/*drug therapy , Rituximab/*adverse effects, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Female ; Hematologic Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Rituximab/administration & dosage

المؤلفون: Mohamedbhai SG; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Edwards N, Morris EC, Mackinnon S, Thomson KJ, Peggs KS

المصدر: British journal of haematology [Br J Haematol] 2012 Feb; Vol. 156 (4), pp. 516-22. Date of Electronic Publication: 2011 Dec 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft Rejection* , Hematopoietic Stem Cell Transplantation*/adverse effects , Lymphocyte Depletion* , Lymphocyte Transfusion* , Transplantation Chimera*, Antibodies, Monoclonal, Humanized/*therapeutic use , T-Lymphocytes/*drug effects, Adolescent ; Adult ; Aged ; Alemtuzumab ; Female ; Humans ; Leukemia/drug therapy ; Leukemia/therapy ; Lymphoma/drug therapy ; Lymphoma/therapy ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Homologous ; Young Adult

المؤلفون: Mohamedbhai SG; Department of Haematology, University College London Hospitals NHS Foundation Trust, UK., Sibson K, Marafioti T, Kayani I, Lowry L, Goldstone AH, Linch DC, Ardeshna KM

المصدر: British journal of haematology [Br J Haematol] 2011 Jan; Vol. 152 (2), pp. 175-81. Date of Electronic Publication: 2010 Nov 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, B-Cell/*drug therapy, Adult ; Aged ; Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cell Proliferation ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Female ; Follow-Up Studies ; Humans ; Ifosfamide/administration & dosage ; Ifosfamide/adverse effects ; Lymphoma, B-Cell/pathology ; Male ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Rituximab ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects ; Young Adult

SCR Protocol: ANAVACYM protocol; IVAC protocol